期刊文献+

缓激肽诱发胶质瘤细胞释放的肿瘤坏死因子-α对体外血瘤屏障的影响 被引量:2

In Vitro Effect of TNF-α Expression Induced by Bradykinin in Glioma Cells on the Blood-Tumor Barrier
下载PDF
导出
摘要 目的:探讨缓激肽(bradykinin,BK)诱发胶质瘤细胞释放的肿瘤坏死因子-α(TNF-α)对体外血瘤屏障的影响及其作用机制。方法:分别用缓激肽和生理盐水作用于C6胶质瘤细胞及神经胶质细胞后,放射免疫法检测0、5、10、15、30和60 min时培养液内TNF-α的浓度。用原代培养的脑微血管内皮细胞(BMEC)和C6细胞共培养构建血瘤屏障模型。将缓激肽处理C6细胞不同时间点的条件培养液(C6CM)作用于屏障模型后,动态观察屏障的通透性及跨内皮阻抗(TER)的改变,并用免疫荧光技术检测脑微血管内皮细胞的紧密连接蛋白occludin的表达,RT-PCR法检测屏障模型脑微血管内皮细胞中核因子-κB(NF-κB)的变化。结果:缓激肽作用于C6细胞后,培养液内TNF-α浓度较对照组明显增加(P<0.05),而神经胶质细胞无明显变化。C6CM作用于血瘤屏障模型后,血瘤屏障通透性增加,跨内皮阻抗减小,而内皮细胞间的紧密连接蛋白occludin表达和核因子-κB的转录水平降低,直至30 min后NF-κB转录水平逐渐增强。结论:缓激肽诱发了胶质瘤细胞释放TNF-α,释放的TNF-α可通过NF-KB影响紧密连接蛋白occludin表达而影响血瘤屏障通透性。 Objective: To assess the in vitro effect and mechanism of tumor necrosis factor-or ( TNF - α ) expression induced by bradykinin ( BK ) in glioma cells on the blood-tumor barrier ( BTB ). Methods: A radioimmunoassay was used to dynamically monitor the TNF-α content in a nutrient fluid at 0, 5, 10, 15, 30, and 60 min time points after BK treatment of C6 cells and glial cells. An in vitro BTB model was established using a coculture of brain microvascular endothelial cells ( BMEC ) and C6 cells. The effect of a BK- treated C6 conditioned medium ( C6CM ) on the levels of nuclear transcription factor kappa B ( NF -κB ) mRNA was investigated by PCR. The occludin expression, as well as the transendothelial resistance ( TER ) and permeability of BTB, was also investigated via the immunofluorescence technique. Results: The TNF-α content in the nutrient fluid of the C6 cells clearly increased after BK treatment compared with that of the control group; however, the glial cells showed no such result. C6CM acted on BTB in vitro, resulting in the decrease in the NF-κB mRNAand occludin expression levels until the minimum was reached at 15 min. Meanwhile, the permeability of BTB increased, whereas TER decreased. Conclusion: BK induced the C6 cells to release TNF-α TNF-α in turn inhibited NF-κB transcription and reduced the occlu- din expression. These mechanisms may explain the effects of TNF-α n the opening of BTB using BK.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第12期822-825,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助项目(编号:81101912) 河北省卫生厅科研基金项目(编号:20100465 20110165) 国家教育部新教师基金(编号:20102134120007) 辽宁省博士启动基金(编号:20101109)资助 Scientific Research Foundation of Tangshan(No.111302048b)~~
关键词 缓激肽 肿瘤坏死因子-Α 血瘤屏障模型 紧密连接蛋白 Bradykinin Tumor necrosis factorα Blood-tumor barrier model Tight junction protein
  • 相关文献

参考文献10

  • 1C6t6 J, Savard M, Bovenzi V, et al. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2) NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study[J]. Neu- ropeptides, 2010, 44(2): 177-185.
  • 2On LJ, Gu YT, Zhang H, et al. Bradykinin-induced blood-minor barrier opening is mediated by tumor necrosis factor-alpha[J]. Neu- rosci Lett 2009, 450 (2): 172-175.
  • 3Hurst RD, Fritz LB. Properties of an immortalized vascular endothelial/ glioma cell co-culture model of the blood-brain barrier [J]. j Cell Physiol, 1996, 167(1): 81-88.
  • 4Harford-Wright E, Lewis KM, Vink R. Towards drug discovery ibr brain tumours: interaction of kinins and tumours at the blood brain barrier interface[J]. Recent Pat CNS Drug Discov, 2011, 6(1):31-40.
  • 5Thompson EM, Frenkel EP, Neuwelt EA. The paradoxical effect of bevacizumab in the therapy of malignant gliomas[J]. Neurology, 2011, 76(1): 87-93.
  • 6Raslan F, Schwarz T, Meuth SG, et al. Inhibition of bradykinin re ceptor B1 protects nfice from focal brain injury by reducing blood - brain barrier leakage and intlammation[J]. J Cerebr Blood Flow Me tabol, 2010, 30(8): 1477-1486.
  • 7Zweckberger K, Plesifila N. Anatibant, a selective non-peptide bra- dykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury[J]. Neurosci Lett, 2009, 454(2):115-117.
  • 8Om LJ, Gu YT, Zhang H, et al. Bradykinin-induced blood-tumor barrier opening is mediated by tumor necrosis factor-alpha0]. Neu- rosci Lett, 2009, 450(2): 172-175.
  • 9Wachtel M, Bolliger MF, Ishihara H, et al. Down-regulation of oc- cludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-kappaB acti- vation[J],J Neurochem, 2001, 78(1): 155-162.
  • 10Kazumasa M, Mikio F, Yoshida Y, et al. Molecular architecture of tight junctions of periderm differs from that of the maculae occludentes of epidermis[J].J Invest Dermatol, 2002, 118(6): 1073-1079.

同被引文献14

  • 1张敏.生理学教学中激发学生学习动机提高学习兴趣探讨[J].山西医科大学学报(基础医学教育版),2006,8(3):256-257. 被引量:21
  • 2Harford-Wright E, Lewis KM, Vink R. Towards drug discovery for brain tumours:interaction of kinins and tumours at the blood brain barrier interface[J]. Recent Pat CNS Drug Discov,2011,6( 1 ) :31 -40.
  • 3Thompson EM, Frenkel EP, Neuwelt EA. The paradoxical effect of bevacizumab in the therapy of malignant gliomas [ J ]. Neurology, 2011,76(1) :87 -93.
  • 4Reynolds DS, Morton AJ. Changes in blood-brain barrier permeability following neurotoxic lesions of rat brain can he visualised with trypan blue [ J 1. J Neurosci Methods, 1998,79 ( 1 ) : 115 - 121.
  • 5Fisher B, Leighton C, Macdonald D, et al. The dose-volume interac- tion in adult supratentorial low-grade glioma: higher radiation dose is beneficial among patients with partial resection [ J ]. J Neurooncol, 2007,82(2) :165 - 170.
  • 6Gururangan S, Fisher MJ, Allen JC, et al. Temozolomide in Children with progressive low-grade glioma [ J 1. Neuro-oneo1,2007,9 ( 2 ) : 161 - 168.
  • 7Hau P, Koch D, Hundsberger T, et al. Safety and feasibility of long- term temozolomide treatment in patients with high-grade glioma [ J ]. Neurology,2007,68 (9) :688 - 690.
  • 8Van Ostade X,Vandenabeele P,Everaerdt B,et al. Human TNF mu- tants with selective activity on the p55 receptor[ J]. Nature, 1993, 361 (6409) :266 -269.
  • 9朱大年主编.生理学第7版[M].北京:人民卫生出版社,2009,1--395.
  • 10Qin LJ, Gu YT, Zhang H, et al. Bradykinin-induced blood-tumor barrier opening is mediated by tumor necrosis factor-alpha[J].Neu- rosci Lett, 2009, 450(2): 172-175.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部